Privia Health Group had its Relative Strength (RS) Rating upgraded from 65 to 71 Friday — a welcome improvement, but still below the 80 or better score you prefer to see.
This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
History reveals that the best stocks often have an 80 or higher RS Rating in the early stages of their moves. See if Privia Health Group can continue to show renewed price strength and clear that threshold.
Can You Really Time The Stock Market?
Now is not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to offer and clear a proper buy point.
Top and bottom line growth moved higher in the company's most recent quarter. Earnings were up 18%, compared to 12% in the prior report. Revenue increased from 2% to 5%.
Privia Health Group earns the No. 5 rank among its peers in the Computer Software-Medical industry group. Doximity is the No. 1-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
